Alan  Muney net worth and biography

Alan Muney Biography and Net Worth

Dr. Muney has more than 25 years experience in leading health plan operations and in medical group practice management. Prior to joining Cigna, he was an executive director of The Blackstone Group, where he served as chief executive officer and founder of the Equity Healthcare on behalf of Blackstone. Previously he was chief medical officer for Oxford Health Plans and for UnitedHealthcare in the New England region, chief medical officer for Avanti Health Systems of NYLCare, and regional medical director and director of pediatrics of Mullikin Medical Centers in California.

Board-certified in pediatrics, Dr. Muney is a graduate of Brown University, where he received both his bachelor’s and medical degrees. He completed his internship, residency and fellowship in pediatrics at Washington University Medical Center in St. Louis and received a master’s of healthcare administration degree from the University of La Verne in La Verne, Calif. He is licensed to practice in the states of Connecticut, New York and California.

Dr. Muney has served on the Brown Medical School Alumni Board of Directors and on the Board of Directors of the Fairfield County chapter of American Heart Association. He has also served on the editorial advisory boards of the American Journal of Managed Care and Health Plan Magazine and on the scientific advisory board of the Institute for the Study of Aging.

What is Alan Muney's net worth?

The estimated net worth of Alan Muney is at least $10.34 million as of November 27th, 2017. Dr. Muney owns 28,457 shares of The Cigna Group stock worth more than $10,340,705 as of March 28th. This net worth approximation does not reflect any other assets that Dr. Muney may own. Learn More about Alan Muney's net worth.

How do I contact Alan Muney?

The corporate mailing address for Dr. Muney and other The Cigna Group executives is 900 COTTAGE GROVE ROAD, BLOOMFIELD CT, 06002. The Cigna Group can also be reached via phone at (860) 226-6000 and via email at [email protected]. Learn More on Alan Muney's contact information.

Has Alan Muney been buying or selling shares of The Cigna Group?

Alan Muney has not been actively trading shares of The Cigna Group during the last ninety days. Most recently, Alan Muney sold 15,345 shares of the business's stock in a transaction on Monday, November 27th. The shares were sold at an average price of $200.80, for a transaction totalling $3,081,276.00. Following the completion of the sale, the executive vice president now directly owns 28,457 shares of the company's stock, valued at $5,714,165.60. Learn More on Alan Muney's trading history.

Who are The Cigna Group's active insiders?

The Cigna Group's insider roster includes Mary Agolglia Hoeltzel (VP), Lisa Bacus (EVP), David Cordani (CEO), Brian Evanko (Exec. VP & CFO ), Brian Evanko (CFO), Eric Foss (Director), Elder Granger (Director), Isaiah Harris, Jr. (Chairman), Mary Hoeltzel (CAO), Nicole Jones (EVP), Matthew Manders (Insider), Thomas McCarthy (CFO), Steven Miller (EVP), Alan Muney (EVP), John Murabito (EVP), Everett Neville (EVP), Eric Palmer (CFO), John Partridge (Director), William Roper (Director), Cynthia Ryan (EVP), Jason Sadler (Insider), Paul Sanford (EVP), Michael Triplett (Insider), Timothy Wentworth (CEO), and Donna Zarcone (Director). Learn More on The Cigna Group's active insiders.

Are insiders buying or selling shares of The Cigna Group?

During the last year, insiders at the health services provider sold shares 18 times. They sold a total of 154,668 shares worth more than $50,986,538.23. The most recent insider tranaction occured on March, 25th when CEO David Cordani sold 31,209 shares worth more than $11,084,500.53. Insiders at The Cigna Group own 0.6% of the company. Learn More about insider trades at The Cigna Group.

Information on this page was last updated on 3/25/2024.

Alan Muney Insider Trading History at The Cigna Group

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
11/27/2017Sell15,345$200.80$3,081,276.0028,457View SEC Filing Icon  
See Full Table

Alan Muney Buying and Selling Activity at The Cigna Group

This chart shows Alan Muney's buying and selling at The Cigna Group by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

The Cigna Group Company Overview

The Cigna Group logo
The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers. The company's Cigna Healthcare segment offers medical, pharmacy, behavioral health, dental, and other products and services for insured and self-insured customers; Medicare Advantage, Medicare Supplement, and Medicare Part D plans for seniors, as well as individual health insurance plans; and health care coverage in its international markets, as well as health care benefits for mobile individuals and employees of multinational organizations. In addition, it offers permanent insurance contracts sold to corporations to provide coverage on the lives of certain employees for financing employer-paid future benefit obligations. The company distributes its products and services through insurance brokers and consultants; directly to employers, unions and other groups, or individuals; and private and public exchanges. The company was formerly known as Cigna Corporation and changed its name to The Cigna Group in February 2023. The Cigna Group was founded in 1792 and is headquartered in Bloomfield, Connecticut.
Read More

Today's Range

Now: $363.38
Low: $359.53
High: $364.71

50 Day Range

MA: $332.16
Low: $297.92
High: $357.73

2 Week Range

Now: $363.38
Low: $240.50
High: $364.71

Volume

1,467,539 shs

Average Volume

1,667,129 shs

Market Capitalization

$106.24 billion

P/E Ratio

20.90

Dividend Yield

1.58%

Beta

0.55